Sanofi-aventis and GEICAM (Grupo Espanol de Investigacion en person de Mama) declared that for women with high-risk node-negative primeval initiate boob cancer adjuvant communication (post surgery) with Taxotere(R) (docetaxel) Injection Concentrate as conception of the TAC program (Taxotere(R), doxorubicin, cyclophosphamide) was related with a momentous transformation in Disease Free Survival (DFS) compared to a accepted FAC program (5-Fluorouracil, doxorubicin, cyclophosphamide) in the GEICAM 9805/Target-0 study. The results module be presented at the 2008 period gathering of the dweller Society of Clinical Oncology, ASCO, in metropolis (Monday June 2, 2008, 2-6 pm, bill sort 1D, nonfigurative 542). In aggregation and North America, most boob cancer pati…

Tags: Annual Meeting, ATM, Breast, breast cancer, Cancer, chemotherapy, Europe, Risk, surgery